cocaine abuse
Information
- Disease name
- cocaine abuse
- Disease ID
- DOID:809
- Description
- "A substance abuse that involves the recurring use of cocaine despite negative consequences." [url:http\://en.wikipedia.org/wiki/Cocaine_Abuse]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04907357 | Active, not recruiting | N/A | rTMS for Stimulant Use Disorders | February 4, 2022 | July 2024 |
| NCT00217997 | Completed | Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals | September 2005 | January 2013 | |
| NCT00218023 | Completed | Phase 2 | Medications for Stopping Cocaine Dependence and Preventing Relapse | March 2006 | April 2012 |
| NCT01651377 | Completed | Phase 1 | Pramipexole as a Treatment for Cocaine Dependence | October 2011 | December 2012 |
| NCT01366001 | Completed | Phase 1 | ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine | August 2011 | February 2012 |
| NCT01401270 | Completed | N/A | Prize Contingency Management for Cocaine-Dependent Methadone Patients | November 2011 | May 2018 |
| NCT01437293 | Completed | Phase 1 | Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE) | August 2010 | April 2012 |
| NCT01601730 | Completed | Phase 1 | Modafinil - Escitalopram Study for Cocaine Dependence | August 2010 | July 2011 |
| NCT01601743 | Completed | N/A | Exercise as a Behavioral Treatment for Cocaine Dependence | September 2011 | July 2014 |
| NCT01651364 | Completed | Phase 1 | A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence | July 2011 | October 2011 |
| NCT02141620 | Completed | Early Phase 1 | n-Acetylcysteine and Cocaine | May 2014 | April 2016 |
| NCT02393599 | Completed | Phase 1 | Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin | May 2015 | September 2015 |
| NCT02563769 | Completed | Phase 1 | Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study | October 24, 2016 | May 25, 2018 |
| NCT03971097 | Completed | N/A | The Effect of Self-Forgiveness on Self-Stigma in Addiction. | August 1, 2019 | December 31, 2019 |
| NCT00218075 | Completed | Phase 2 | Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence | March 2000 | October 2007 |
| NCT00218257 | Completed | N/A | Progesterone for the Treatment of Cocaine Dependence - 1 | July 2002 | June 30, 2008 |
| NCT00223236 | Completed | Phase 3 | Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence | July 2010 | May 2012 |
| NCT00227903 | Completed | Phase 2 | Therapeutic Substance Abuse Treatment in Pregnancy - 1 | September 2004 | August 2010 |
| NCT00249457 | Completed | N/A | Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 | October 1996 | January 2006 |
| NCT00292123 | Completed | Phase 1 | Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse | June 1999 | August 2006 |
| NCT00318760 | Completed | Phase 1 | Effect of Clonidine on Responses to Imagery Scripts | June 14, 2005 | August 7, 2013 |
| NCT00350610 | Completed | Phase 1 | Computer-Based Training in Cognitive Behavior Therapy | November 2007 | December 2012 |
| NCT00350870 | Completed | Phase 1 | CBT With Disulfiram and Contingency Management | April 2005 | December 2010 |
| NCT00373880 | Completed | Phase 2 | Effects of Aripiprazole on Cocaine Craving and Self-Administration | April 2005 | September 2008 |
| NCT00606801 | Completed | N/A | Galantamine Effects on Cognitive Function in Abstinent Cocaine Users | June 2007 | February 2009 |
| NCT00631748 | Completed | N/A | Quetiapine for the Reduction of Cocaine Use | February 2008 | July 2010 |
| NCT00842517 | Completed | Phase 1 | Long Term Maintenance of Drug Abstinence | September 2004 | August 2008 |
| NCT01010620 | Completed | Screening Protocol for Research Participants | December 2009 | June 1, 2019 | |
| NCT01030692 | Completed | Phase 1 | Rivastigmine and Huperzine A as Treatments for Cocaine Dependence | January 2009 | June 2014 |
| NCT01062945 | Completed | Phase 1 | The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine | January 2010 | January 2011 |
| NCT01249274 | Completed | N/A | Progesterone for Postpartum Cocaine Relapse | February 2011 | July 2013 |
| NCT01327586 | Completed | Phase 2 | Abstinence-Linked Money Management Multisite | December 2009 | January 2014 |
| NCT06045793 | Not yet recruiting | Phase 2 | Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) | December 11, 2023 | June 4, 2024 |
| NCT05824221 | Not yet recruiting | N/A | Effect of rTMS on Neurotrophines Levels in CUD | April 30, 2023 | October 31, 2023 |
| NCT06177860 | Recruiting | Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use | November 17, 2023 | November 30, 2024 | |
| NCT05857852 | Recruiting | N/A | Low-Intensity Focused Ultrasound for Cocaine Use Disorder | March 1, 2023 | March 1, 2025 |
| NCT00439049 | Recruiting | Substance Abuse Pre-Treatment Screening Study | October 2005 | June 2026 | |
| NCT00218049 | Terminated | Phase 1 | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals | December 2004 | July 2005 |
| NCT00218036 | Terminated | Phase 2 | Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8 | July 2006 | February 2010 |
| NCT00142883 | Terminated | N/A | The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 | September 2004 | September 2006 |
| NCT00865332 | Withdrawn | Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates | December 12, 2007 | December 21, 2010 | |
| NCT02233829 | Withdrawn | Early Phase 1 | Dopamine Rhythms in Health and Addiction | April 23, 2024 | April 23, 2024 |
- Disase is a (Disease Ontology)
- DOID:302
- Cross Reference ID (Disease Ontology)
- ICD10CM:F14.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:305.6
- Cross Reference ID (Disease Ontology)
- MESH:D019970
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:78267003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0009171